Invention Grant
US09469613B2 (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
有权
（N-（氰基甲基）-4-（2-（4-吗啉代苯基氨基）嘧啶-4-基）苯甲酰胺
- Patent Title: (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
- Patent Title (中): （N-（氰基甲基）-4-（2-（4-吗啉代苯基氨基）嘧啶-4-基）苯甲酰胺
-
Application No.: US14736690Application Date: 2015-06-11
-
Publication No.: US09469613B2Publication Date: 2016-10-18
- Inventor: Brandon H. Brown , Ernest A. Carra , Jeffrey N. Hemenway , Henry Morrison , Troy Reynolds , Bing Shi , Dimitrios Stefanidis , Fang Wang , Matthew Robert Warr , James Andrew Whitney , Yan Xin
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: GILEAD SCIENCES, INC.
- Current Assignee: GILEAD SCIENCES, INC.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D265/30 ; C07D239/42 ; A61K31/5377
Abstract:
The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
Public/Granted literature
- US20150361050A1 (N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE Public/Granted day:2015-12-17
Information query
